Cargando…

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study

SIMPLE SUMMARY: The early detection of primary resistance to anti-PD1 immunotherapies remains a major challenge in the management of metastatic melanoma. In a previous study, we suggested that early monitoring of circulating tumor DNA (ctDNA) using well-defined evaluation criteria allows the identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herbreteau, Guillaume, Vallée, Audrey, Knol, Anne-Chantal, Théoleyre, Sandrine, Quéreux, Gaëlle, Varey, Emilie, Khammari, Amir, Dréno, Brigitte, Denis, Marc G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069589/ https://www.ncbi.nlm.nih.gov/pubmed/33920470 http://dx.doi.org/10.3390/cancers13081826

Ejemplares similares

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
por: Herbreteau, Guillaume, et al.
Publicado: (2018)

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report
por: Quéreux, Gaelle, et al.
Publicado: (2017)

Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2020)

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014)

Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay
por: Vallée, Audrey, et al.
Publicado: (2019)

Tissue Biomarkers in Melanoma Patients Treated with TIL
por: Knol, Anne-Chantal, et al.
Publicado: (2012)

Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases
por: L’Orphelin, Jean-Matthieu, et al.
Publicado: (2021)

Anxiety, locus of control and sociodemographic factors associated with adherence to an annual clinical skin monitoring: a cross-sectional survey among 1000 high-risk French patients involved in a pilot-targeted screening programme for melanoma
por: Rat, Cédric, et al.
Publicado: (2017)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018)

Proposal for an annual skin examination by a general practitioner for patients at high risk for melanoma: a French cohort study
por: Rat, Cédric, et al.
Publicado: (2015)

MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer
por: Herbreteau, Guillaume, et al.
Publicado: (2021)

Use of Smartphones for Early Detection of Melanoma: Systematic Review
por: Rat, Cédric, et al.
Publicado: (2018)

Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
por: Daguzé, Justine, et al.
Publicado: (2016)

Inclusion of populations at risk of advanced melanoma in an opportunistic targeted screening project involving general practitioners
por: Rat, Cédric, et al.
Publicado: (2016)

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma
por: Labarriere, N., et al.
Publicado: (2013)

Combination of alitretinoin and topical 5-fluorouracil in Darier disease
por: Soenen, Anouk, et al.
Publicado: (2018)

MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
por: Bobinet, Mathilde, et al.
Publicado: (2012)

Dramatic response of an inoperable Merkel cell carcinoma with imatinib
por: Frenard, Cecile, et al.
Publicado: (2016)

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
por: Godet, Yann, et al.
Publicado: (2008)

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas
por: Desfrançois, Juliette, et al.
Publicado: (2010)

Transcriptomics Analysis Indicates Trifarotene Reverses Acne-Related Gene Expression Changes
por: Dreno, Brigitte, et al.
Publicado: (2021)

Draft Genome Sequence of an Erythromycin-Resistant Propionibacterium acnes Isolate Recovered from Folliculitis of the Scalp
por: Aubin, Guillaume Ghislain, et al.
Publicado: (2017)

PD-1 expression conditions T cell avidity within an antigen-specific repertoire
por: Simon, Sylvain, et al.
Publicado: (2015)

The Skin Microbiome: A New Actor in Inflammatory Acne
por: Dréno, Brigitte, et al.
Publicado: (2020)

Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy
por: Zuliani, Thomas, et al.
Publicado: (2013)

Development and accuracy of an artificial intelligence algorithm for acne grading from smartphone photographs
por: Seité, Sophie, et al.
Publicado: (2019)

Lifestyle habits and impact of the Mediterranean diet on facial acne severity in French women: a case-control study
por: Ah-Thiane, Laurie, et al.
Publicado: (2022)

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy
por: Dupuis, Frantz, et al.
Publicado: (2018)

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features
por: Simon, Sylvain, et al.
Publicado: (2018)

General practitioner management related to skin cancer prevention and screening during standard medical encounters: a French cross-sectional study based on the International Classification of Primary Care
por: Rat, Cédric, et al.
Publicado: (2017)

A subset of dendritic cells as a major and constitutive source of IL-22BP
por: Martin, Jérôme, et al.
Publicado: (2011)

Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
por: Zuliani, Thomas, et al.
Publicado: (2011)

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
por: Dréno, Brigitte, et al.
Publicado: (2021)

Beyond PD-1 Immunotherapy in Malignant Melanoma
por: Kwiatkowska, Dominika, et al.
Publicado: (2019)

Prepubertal acne: A retrospective study
por: Frénard, Cécile, et al.
Publicado: (2021)

Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer
por: Allard, Mathilde, et al.
Publicado: (2011)

Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
por: Rohatgi, Anjali, et al.
Publicado: (2021)

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy
por: Simon, Sylvain, et al.
Publicado: (2020)

Transcriptomic features of tumour-infiltrating CD4(low)CD8(high) double positive αβ T cells in melanoma
por: Parrot, Tiphaine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8tcths0hquhvgba3e04mb2l62e